Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001104659-19-016424

Chief Financial Officer bought 5,400 shares at an average $12.58 ($67,939)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Pizzie Nick Chief Financial Officer 2019-03-19 Purchase +60 $12.69 $761 60 I
Pizzie Nick Chief Financial Officer 2019-03-19 Purchase +5,340 $12.58 $67,177 36,340 D
Open-market purchases · 5,400 sh · avg $12.58 · $67,939
Loading xslF345X03/a4.xml…